Last edition
News about "disease progression"
Bristol Myers Squibb Reports Positive RYZ101 Phase 3 Results
Bristol Myers Squibb reports positive interim results from the Phase 3 ACTION-1 trial of investigational radiopharmaceutical therapy RYZ101 in patients with GEP-NETs.
Disease Progression | 14/10/2026 | By News Bureau | 115
Lundbeck to Present Movement Disorder Data at MDS 2026
Lundbeck presents new movement disorder research covering MSA clinical development and advanced Parkinson’s disease.
Disease Progression | 05/10/2026 | By News Bureau | 115
Johns Hopkins Researchers Develop Cloud-Based Microscope for Continuous Brain Monitoring
Johns Hopkins researchers have developed CloudScope, a cloud-based microscope that enables continuous remote monitoring of brain activity and disease-related changes in freely moving mice for more than 24 hours.
Disease Progression | 15/09/2026 | By News Bureau | 129
EU Approves AstraZeneca's Etcamah Combination for ESR1-Mutated Advanced Breast Cancer
The European Commission has approved AstraZeneca’s Etcamah in combination with CDK4/6 inhibitors for ESR1-mutated ER-positive, HER2-negative advanced breast cancer, following Phase 3 data demonstrating a 56% reduction in the risk of disease progression or death.
Disease Progression | 24/07/2026 | By News Bureau | 153
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy